This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Neovasc Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Belangrijke informatie
24.0%
Groei van de winst
101.8%
Groei van de winst per aandeel
Medical Equipment Groei van de industrie | 4.3% |
Inkomstengroei | -4.3% |
Rendement op eigen vermogen | -260.1% |
Nettomarge | -1,082.9% |
Laatste winstupdate | 31 Dec 2022 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Neovasc geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
31 Dec 22 | 4 | -41 | 19 | 18 |
30 Sep 22 | 3 | -34 | 13 | 15 |
30 Jun 22 | 3 | -33 | 14 | 15 |
31 Mar 22 | 3 | -33 | 14 | 14 |
31 Dec 21 | 3 | -25 | 16 | 15 |
30 Sep 21 | 2 | -23 | 17 | 18 |
30 Jun 21 | 2 | -26 | 19 | 20 |
31 Mar 21 | 2 | -27 | 19 | 20 |
31 Dec 20 | 2 | -29 | 16 | 20 |
30 Sep 20 | 2 | -37 | 16 | 21 |
30 Jun 20 | 2 | -33 | 13 | 21 |
31 Mar 20 | 2 | -31 | 12 | 20 |
31 Dec 19 | 2 | -35 | 12 | 20 |
30 Sep 19 | 2 | -11 | 14 | 18 |
30 Jun 19 | 2 | -20 | 18 | 17 |
31 Mar 19 | 2 | -61 | 17 | 16 |
31 Dec 18 | 2 | -108 | 16 | 16 |
30 Sep 18 | 2 | -125 | 19 | 15 |
30 Jun 18 | 3 | -115 | 14 | 16 |
31 Mar 18 | 4 | -71 | 14 | 16 |
31 Dec 17 | 5 | -22 | 14 | 16 |
30 Sep 17 | 7 | 19 | 7 | 19 |
30 Jun 17 | 9 | -5 | 7 | 19 |
31 Mar 17 | 9 | -83 | 7 | 20 |
31 Dec 16 | 10 | -86 | 7 | 19 |
30 Sep 16 | 9 | -131 | 7 | 19 |
30 Jun 16 | 8 | -110 | 7 | 19 |
Kwaliteitswinsten: G5Z is currently unprofitable.
Groeiende winstmarge: G5Z is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: G5Z is unprofitable, but has reduced losses over the past 5 years at a rate of 24% per year.
Versnelling van de groei: Unable to compare G5Z's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: G5Z is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-26.9%).
Rendement op eigen vermogen
Hoge ROE: G5Z has a negative Return on Equity (-260.14%), as it is currently unprofitable.